Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses

Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite

(2021) Gabriele Cerutti et al.   Cell Host & Microbe

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

(2021) Chang Liu et al.   CELL

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021

(2021) Finlay Campbell et al.   Eurosurveillance

How the coronavirus infects cells — and why Delta is so dangerous

(2021) Megan Scudellari   NATURE

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

(2020) Christopher O. Barnes et al.   CELL

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

(2020) Bette Korber et al.   CELL

Infectivity of SARS-CoV-2: there Is Something More than D614G?

(2020) Saathvik R. Kannan et al.   Journal of Neuroimmune Pharmacology

Spike mutation D614G alters SARS-CoV-2 fitness

(2020) Jessica A. Plante et al.   NATURE

Emergence of a Highly Fit SARS-CoV-2 Variant

(2020) Ralph S. Baric   NEW ENGLAND JOURNAL OF MEDICINE

Nextstrain: real-time tracking of pathogen evolution

(2018) James Hadfield et al.   BIOINFORMATICS